Nuvalent, Inc. 3 SEC Filings

Filed On	Filing
20 Mar 2026	Form 3: Lane Benjamin, See Remarks Holds 40,868 shares of Class A Common Stock
11 Dec 2025	Form 3: Squarer Ron, Director No securities owned
20 Jun 2025	Form 3: Oliger Christy J., Director No securities owned
09 Dec 2024	Form 3: Bogle Grant C., Director No securities owned
11 Jul 2024	Form 3: Pelish Henry E., Chief Scientific Officer Holds 63,495 shares of Class A Common Stock
07 Nov 2022	Form 3: Deerfield PARTNERS, L.p., Director Holds 650,000 shares of Class A Common Stock
06 Oct 2022	Form 3: Meyers Michael L., Director
31 Mar 2022	Form 3: Protopapas Anna, Director No securities owned
03 Feb 2022	Form 3: Conley Emily, Director Holds 8 shares of Common stock
28 Jul 2021	Form 3: Shair Matthew, Director Holds 2,164,698 shares of Class A Common Stock
28 Jul 2021	Form 3: Jackson Robert Bowers, Director No securities owned
28 Jul 2021	Form 3: Pearlberg Joseph, Director No securities owned
28 Jul 2021	Form 3: Porter James Richard, Director Holds 75,313 shares of Class A Common Stock
28 Jul 2021	Form 3: Miller Deborah Ann, Chief Legal Officer
28 Jul 2021	Form 3: Srivastava Sapna, Director No securities owned
28 Jul 2021	Form 3: Gilliland Dwight Gary, Director
28 Jul 2021	Form 3: Noci Darlene, See Remarks
28 Jul 2021	Form 3: Wheeler Cameron, Director No securities owned
28 Jul 2021	Form 3: Balcom Alexandra, Chief Financial Officer
28 Jul 2021	Form 3: Turner Christopher Durant, Chief Medical Officer

Comments